Intravenously administered high dose ascorbic acid (HDIVC) as used in cases of patients who have cancer has considerable mythology surrounding it. The purpose of this review is not to exhaustively recap the data regarding this therapy but rather to address basicissues of safety, pharmacology and outcomes of ongoing research.
1 HDIVC Information for Patients and Physicians
More IV Monographs
8a GSH Augmentation and Cell Protection
GlutathioneUse in cell repair and augmentation of parenteral glutathione before and after administration:Rationale and formula developed for the BIORC –
8 Radiation Injury Therapy and GSH
Rationale and formula developed for the BIORC – AMSA Clinics during the integrative oncology study.